NeuBase Therapeutics Stock Forecast - 8 Period Moving Average
| NBSE Stock | USD 0.41 0.01 2.38% |
The 8 Period Moving Average forecasted value of NeuBase Therapeutics on the next trading day is expected to be 0.42 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.41. NeuBase Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast NeuBase Therapeutics stock prices and determine the direction of NeuBase Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of NeuBase Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns. Although NeuBase Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of NeuBase Therapeutics' systematic risk associated with finding meaningful patterns of NeuBase Therapeutics fundamentals over time.
Check out Historical Fundamental Analysis of NeuBase Therapeutics to cross-verify your projections. NeuBase |
Open Interest Against 2032-10-21 NeuBase Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast NeuBase Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in NeuBase Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for NeuBase Therapeutics stock based on available contracts left at the end of a trading day.
No Open InterestPlease note that to derive more accurate forecasting about market movement from the current NeuBase Therapeutics' open interest, investors have to compare it to NeuBase Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of NeuBase Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in NeuBase. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in NeuBase Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the NeuBase Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets NeuBase Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
An 8-period moving average forecast model for NeuBase Therapeutics is based on an artificially constructed time series of NeuBase Therapeutics daily prices in which the value for a trading day is replaced by the mean of that value and the values for 8 of preceding and succeeding time periods. This model is best suited for price series data that changes over time. NeuBase Therapeutics 8 Period Moving Average Price Forecast For the 8th of May
Given 90 days horizon, the 8 Period Moving Average forecasted value of NeuBase Therapeutics on the next trading day is expected to be 0.42 with a mean absolute deviation of 0.08, mean absolute percentage error of 0.02, and the sum of the absolute errors of 4.41.Please note that although there have been many attempts to predict NeuBase Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that NeuBase Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
NeuBase Therapeutics Stock Forecast Pattern
| Backtest NeuBase Therapeutics | NeuBase Therapeutics Price Prediction | Buy or Sell Advice |
NeuBase Therapeutics Forecasted Value
In the context of forecasting NeuBase Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. NeuBase Therapeutics' downside and upside margins for the forecasting period are 0 and 8.87, respectively. We have considered NeuBase Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 8 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of NeuBase Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent NeuBase Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 99.6393 |
| Bias | Arithmetic mean of the errors | 0.0242 |
| MAD | Mean absolute deviation | 0.0832 |
| MAPE | Mean absolute percentage error | 0.1557 |
| SAE | Sum of the absolute errors | 4.41 |
Predictive Modules for NeuBase Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NeuBase Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NeuBase Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for NeuBase Therapeutics
For every potential investor in NeuBase, whether a beginner or expert, NeuBase Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. NeuBase Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in NeuBase. Basic forecasting techniques help filter out the noise by identifying NeuBase Therapeutics' price trends.NeuBase Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NeuBase Therapeutics stock to make a market-neutral strategy. Peer analysis of NeuBase Therapeutics could also be used in its relative valuation, which is a method of valuing NeuBase Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
NeuBase Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of NeuBase Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of NeuBase Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
NeuBase Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how NeuBase Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NeuBase Therapeutics shares will generate the highest return on investment. By undertsting and applying NeuBase Therapeutics stock market strength indicators, traders can identify NeuBase Therapeutics entry and exit signals to maximize returns.
NeuBase Therapeutics Risk Indicators
The analysis of NeuBase Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in NeuBase Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neubase stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.99 | |||
| Standard Deviation | 8.21 | |||
| Variance | 67.47 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of NeuBase Therapeutics to cross-verify your projections. For information on how to trade NeuBase Stock refer to our How to Trade NeuBase Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for NeuBase Stock analysis
When running NeuBase Therapeutics' price analysis, check to measure NeuBase Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuBase Therapeutics is operating at the current time. Most of NeuBase Therapeutics' value examination focuses on studying past and present price action to predict the probability of NeuBase Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuBase Therapeutics' price. Additionally, you may evaluate how the addition of NeuBase Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is NeuBase Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuBase Therapeutics. If investors know NeuBase will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuBase Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (18.60) | Return On Assets (0.43) | Return On Equity (0.93) |
The market value of NeuBase Therapeutics is measured differently than its book value, which is the value of NeuBase that is recorded on the company's balance sheet. Investors also form their own opinion of NeuBase Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is NeuBase Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuBase Therapeutics' market value can be influenced by many factors that don't directly affect NeuBase Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuBase Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuBase Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuBase Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.